Li Jingyi, Lin Qian, Ren Chao, Li Xiaodong, Li Xiaowei, Li Haofeng, Li Shadan
Department of Urology, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Department of General Surgery (Vascular Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Int J Surg. 2025 May 1;111(5):3430-3440. doi: 10.1097/JS9.0000000000002362.
The mitochondria-associated endoplasmic reticulum membrane (MAM) is a crucial structure connecting mitochondria and the endoplasmic reticulum (ER), regulating intracellular calcium homeostasis, lipid metabolism, and various signaling pathways essential for arterial health. Recent studies highlight MAM's significant role in modulating vascular endothelial cells (EC) and vascular smooth muscle cells (VSMC), establishing it as a key regulator of arterial health and a contributor to vascular disease pathogenesis. Organ transplantation is the preferred treatment for end-stage organ failure, but transplant arteriosclerosis (TA) can lead to chronic transplant dysfunction, significantly impacting patient survival. TA, like other vascular diseases, features endothelial dysfunction and abnormal proliferation and migration of VSMC. Previous research on TA has focused on immune factors; the pathological and physiological changes in grafts following immune system attacks have garnered insufficient attention. For example, the potential roles of MAM in TA have not been thoroughly investigated. Investigating the relationship between MAM and TA, as well as the mechanisms behind TA progression, is essential. This review aims to outline the fundamental structure and the primary functions of MAM, summarize its key molecular regulators of vascular health, and explore future prospects for MAM in the context of TA research, providing insights for both basic research and clinical management of TA.
线粒体相关内质网膜(MAM)是连接线粒体和内质网(ER)的关键结构,调节细胞内钙稳态、脂质代谢以及对动脉健康至关重要的各种信号通路。最近的研究强调了MAM在调节血管内皮细胞(EC)和血管平滑肌细胞(VSMC)方面的重要作用,确立了它作为动脉健康的关键调节因子以及血管疾病发病机制的促成因素。器官移植是终末期器官衰竭的首选治疗方法,但移植动脉硬化(TA)可导致慢性移植功能障碍,对患者生存产生重大影响。TA与其他血管疾病一样,具有内皮功能障碍以及VSMC异常增殖和迁移的特征。以往对TA的研究主要集中在免疫因素上;免疫系统攻击后移植物的病理和生理变化尚未得到足够关注。例如,MAM在TA中的潜在作用尚未得到充分研究。研究MAM与TA之间的关系以及TA进展背后的机制至关重要。本综述旨在概述MAM的基本结构和主要功能,总结其对血管健康的关键分子调节因子,并探讨MAM在TA研究背景下的未来前景,为TA的基础研究和临床管理提供见解。